In the lab, Michigan Medicine researchers are developing new approaches to tackling this deadly type of brain cancer.

In mouse models, the work uncovers a new potential target to improve immunotherapy approaches to the deadly disease.

Proof-of-concept research points to wearable monitors’ potential to offer low-cost, non-invasive way to detect this dangerous bone-marrow transplant complication.

An innovative way of assessing clinical trial-related imaging could reduce the kinds of errors that can distort results, study finds.

Members of the U-M Rogel Cancer Center continue to push the boundaries of cancer prevention, diagnosis and treatment.

A potent and selective degrader of the transcription factor STAT3 offers a new approach to a previously “undruggable” target.